Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
University of York
Headquarters:
York, United Kingdom
Website:
http://www.york.ac.uk
Year Founded:
1963
Status:
Non-biopharma
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Sep 2, 2017
Strategy
Pathfinding for access
Novartis’ pathfinding value-based deal with CMS for CAR T therapy Kymriah
Read More
BioCentury
|
Aug 24, 2017
Translation in Brief
The skinny on leishmaniasis
Lethal Leishmania parasite abundant in skin patches
Read More
BioCentury
|
Jul 21, 2017
Strategy
Accessing miracles
How access could be an issue for Novartis’ tisagenlecleucel CAR T
Read More
BioCentury
|
Mar 8, 2017
Distillery Therapeutics
Infectious disease
Read More
BioCentury
|
Mar 30, 2016
Top Story
NICE eyes alternative payment models for cell therapies
Read More
BioCentury
|
Mar 16, 2015
Emerging Company Profile
Genomic-linked outcomes
How 14M Genomics will link cancer genome profiling to clinical outcomes
Read More
BioCentury
|
Feb 20, 2015
Politics & Policy
U.K. researchers: NICE's QALY threshold is too high
Read More
BioCentury
|
Feb 16, 2015
Company News
14M Genomics, University of York deal
Read More
BioCentury
|
Aug 19, 2013
Company News
Stem Cell Therapeutics, University of York deal
Read More
BioCentury
|
Aug 1, 2013
Targets & Mechanisms
Prostate cancer's nerves
Read More
Items per page:
10
1 - 10 of 25